keyword
https://read.qxmd.com/read/38344336/the-therapeutic-mechanisms-and-beneficial-effects-of-ursodeoxycholic-acid-in-the-treatment-of-nonalcoholic-fatty-liver-disease-a-systematic-review
#21
REVIEW
Sorina Ionelia Stan, Viorel Biciuşcă, Diana Clenciu, Adina Mitrea, Mihai-Virgil Boldeanu, Patricia Durand, Suzana Dănoiu
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, with an increasing prevalence in all regions of the world. Its spectrum includes hepatic steatosis (HS) and non-alcoholic steatohepatitis (NASH) with progression to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). NAFLD may represent the hepatic manifestation of the metabolic syndrome (MS), with a prevalence directly proportional to the prevalence of obesity and MS. The standard treatment for patients with NAFLD is lifestyle modification, which in medical practice has many limitations...
January 2024: Medicine and pharmacy reports
https://read.qxmd.com/read/38331795/what-are-the-common-downstream-molecular-events-between-alcoholic-and-nonalcoholic-fatty-liver
#22
REVIEW
Giovanni Tarantino, Vincenzo Citro
Liver fat storage, also called hepatic steatosis, is increasingly common and represents a very frequent diagnosis in the medical field. Excess fat is not without consequences. In fact, hepatic steatosis contributes to the progression toward liver fibrosis. There are two main types of fatty liver disease, alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). Although AFLD and NAFLD are similar in their initial morphological features, both conditions involve the same evolutive forms...
February 8, 2024: Lipids in Health and Disease
https://read.qxmd.com/read/38325120/prioritising-genetic-findings-for-drug-target-identification-and-validation
#23
REVIEW
Nikita Hukerikar, Aroon D Hingorani, Folkert W Asselbergs, Chris Finan, Amand F Schmidt
The decreasing costs of high-throughput genetic sequencing and increasing abundance of sequenced genome data have paved the way for the use of genetic data in identifying and validating potential drug targets. However, the number of identified potential drug targets is often prohibitively large to experimentally evaluate in wet lab experiments, highlighting the need for systematic approaches for target prioritisation. In this review, we discuss principles of genetically guided drug development, specifically addressing loss-of-function analysis, colocalization and Mendelian randomisation (MR), and the contexts in which each may be most suitable...
January 26, 2024: Atherosclerosis
https://read.qxmd.com/read/38312594/the-staging-of-nonalcoholic-fatty-liver-disease-fibrosis-a-comparative-study-of-mr-elastography-and-the-quantitative-dce-mri-exchange-model
#24
JOURNAL ARTICLE
Hao Ren, Dawei Yang, Hui Xu, Xiaofei Tong, Xinyan Zhao, Qianyi Wang, Yameng Sun, Xiaojuan Ou, Jidong Jia, Hong You, Zhenchang Wang, Zhenghan Yang
OBJECTIVES: To evaluate the efficacy and image processing time of the dynamic contrast-enhanced MRI (DCE-MRI) exchange model in liver fibrosis staging and compare it to the efficacy of magnetic resonance elastography (MRE). METHODS: The subjects were 45 patients with nonalcoholic fatty liver disease (NAFLD) who underwent MRE and DCE-MRI in our hospital. Liver biopsy results were available for all patients. Spearman rank correlation coefficients were used to compare the correlations among MRE, DCE-MRI and liver fibrosis parameters...
January 30, 2024: Heliyon
https://read.qxmd.com/read/38311058/a-composite-blood-biomarker-including-akr1b10-and-cytokeratin-18-for-progressive-types-of-nonalcoholic-fatty-liver-disease
#25
JOURNAL ARTICLE
Seung Joon Choi, Sungjin Yoon, Kyoung-Kon Kim, Doojin Kim, Hye Eun Lee, Kwang Gi Kim, Seung Kak Shin, Ie Byung Park, Seong Min Kim, Dae Ho Lee
BACKGROUND: We aimed to evaluate whether composite blood biomarkers including aldo-keto reductase family 1 member B10 (AKR1B10) and cytokeratin 18 (CK-18; a nonalcoholic steatohepatitis [NASH] marker) have clinically applicable performance for the diagnosis of NASH, advanced liver fibrosis, and high-risk NASH (NASH+significant fibrosis). METHODS: A total of 116 subjects including healthy control subjects and patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) were analyzed to assess composite blood-based and imaging-based biomarkers either singly or in combination...
February 1, 2024: Diabetes & Metabolism Journal
https://read.qxmd.com/read/38302636/effects-of-nonalcoholic-fatty-liver-disease-on-sarcopenia-evidence-from-genetic-methods
#26
JOURNAL ARTICLE
Jiaqin Yuan, Jinglin Zhang, Qiang Luo, Lipeng Peng
With the aging of the population, sarcopenia has become more common. Studies have shown a broad association between liver disease and sarcopenia. However, this link remains unclear. Our study explored the link between NAFLD and sarcopenia and predicting the pathogenesis. To begin, we investigated the causal relationship and genetic correlation between them using MR and LDSC. Second, each GWAS was annotated by MAGMA. The annotated genes were analyzed for pleiotropy using the PLACO approach. Finally, functional analysis was conducted on the identified pleiotropic genes...
February 1, 2024: Scientific Reports
https://read.qxmd.com/read/38254750/masld-and-the-development-of-hcc-pathogenesis-and-therapeutic-challenges
#27
REVIEW
Anju G S Phoolchund, Salim I Khakoo
Metabolic-dysfunction-associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease (NAFLD)) represents a rapidly increasing cause of chronic liver disease and hepatocellular carcinoma (HCC), mirroring increasing rates of obesity and metabolic syndrome in the Western world. MASLD-HCC can develop at an earlier stage of fibrosis compared to other causes of chronic liver disease, presenting challenges in how to risk-stratify patients to set up effective screening programmes. Therapeutic decision making for MASLD-HCC is also complicated by medical comorbidities and disease presentation at a later stage...
January 6, 2024: Cancers
https://read.qxmd.com/read/38240493/mendelian-randomization-study-revealed-causal-relationship-between-nonalcoholic-fatty-liver-disease-and-osteoporosis-fractures
#28
JOURNAL ARTICLE
Xiong Pei, Wei Jiang, Lianchi Li, Qingmin Zeng, Chang-Hai Liu, Ming Wang, Enqiang Chen, Taoyou Zhou, Hong Tang, Dongbo Wu
BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have a higher risk of osteoporosis/fractures; however, the causal relationship remains unclear. METHODS: Publicly available genome-wide association studies (GWASs) were used for Mendelian randomization (MR) analysis. GWASs of NAFLD and fractures were obtained from the FinnGen Consortium. GWASs of bone mineral density (BMD) were derived from a meta-analysis. GWASs of obesity, diabetes, liver function, and serum lipid-related metrics were used to clarify whether the accompanying NAFLD symptoms contributed to fractures...
January 19, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38212362/genetically-determined-circulating-micronutrients-and-the-risk-of-nonalcoholic-fatty-liver-disease
#29
JOURNAL ARTICLE
Ke Liu, Ying Chen, Jiaxin Chen, Weiwei Chen, Xiaohui Sun, Yingying Mao, Ding Ye
Evidence from epidemiological literature on the association of circulating micronutrients with risk of nonalcoholic fatty liver disease (NAFLD) is inconsistent. We aimed to elucidate the causal relationships using Mendelian randomization (MR). Single-nucleotide polymorphisms associated with 14 circulating micronutrients (β-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamin B6, B12, C, D, K1 and zinc) were employed as instrumental variables. Summary level data for NAFLD were obtained from a genome-wide association study (GWAS) meta-analysis of 8434 cases and 770,180 controls (discovery stage) and another two datasets including 1483 NAFLD cases and 17,781 controls (replication stage 1) and 2134 NAFLD cases and 33,433 controls (replication stage 2)...
January 11, 2024: Scientific Reports
https://read.qxmd.com/read/38149094/causal-effects-of-non-alcoholic-fatty-liver-disease-on-osteoporosis-a-mendelian-randomization-study
#30
JOURNAL ARTICLE
Yue Zhou, Yunzhi Ni, Zhihong Wang, Gerald J Prud'homme, Qinghua Wang
BACKGROUND: Osteoporosis (OP) is a systemic skeletal disease characterized by compromised bone strength leading to an increased risk of fracture. There is an ongoing debate on whether non-alcoholic fatty liver disease (NAFLD) is an active contributor or an innocent bystander in the pathogenesis of OP. The aim of this study was to assess the causal association between NAFLD and OP. METHODS: We performed two-sample Mendelian randomization (MR) analyses to investigate the causal association between genetically predicted NAFLD [i...
2023: Frontiers in Endocrinology
https://read.qxmd.com/read/38135975/periodontitis-and-metabolic-syndrome-statistical-and-machine-learning-analytics-of-a-nationwide-study
#31
JOURNAL ARTICLE
Asaf Wilensky, Noa Frank, Gabriel Mizraji, Dorit Tzur, Chen Goldstein, Galit Almoznino
This study aimed to analyze the associations between periodontitis and metabolic syndrome (MetS) components and related conditions while controlling for sociodemographics, health behaviors, and caries levels among young and middle-aged adults. We analyzed data from the Dental, Oral, and Medical Epidemiological (DOME) record-based cross-sectional study that combines comprehensive sociodemographic, medical, and dental databases of a nationally representative sample of military personnel. The research consisted of 57,496 records of patients, and the prevalence of periodontitis was 9...
December 1, 2023: Bioengineering
https://read.qxmd.com/read/38110867/exploration-of-the-causal-effects-of-leukocyte-telomere-length-and-four-gastrointestinal-diseases-a-two-sample-bidirectional-mendelian-randomization-study
#32
JOURNAL ARTICLE
Haikuo Wang, Xiaolin Chen, Siming Wang, Heyun Zhang
BACKGROUND: To explore the underlying causality between leukocyte telomere length (LTL) and four gastrointestinal diseases, we designed a two-sample bidirectional Mendelian randomization study. METHODS: Two-sample Mendelian randomization (MR) was used to explore genetic causality between LTL and four gastrointestinal diseases, including irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), gastrointestinal ulcers disease (GUD), and nonalcoholic fatty liver disease (NAFLD)...
December 18, 2023: BMC Gastroenterology
https://read.qxmd.com/read/38106475/association-between-gut-microbiota-and-nafld-nash-a-bidirectional-two-sample-mendelian-randomization-study
#33
JOURNAL ARTICLE
Qilong Zhai, Hongyu Wu, Siyuan Zheng, Tao Zhong, Changjie Du, Jiajun Yuan, Jialun Peng, Can Cai, Jinzheng Li
BACKGROUND: Recent studies have suggested a relationship between gut microbiota and non-alcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). However, the nature and direction of this potential causal relationship are still unclear. This study used two-sample Mendelian randomization (MR) to clarify the potential causal links. METHODS: Summary-level Genome-Wide Association Studies (GWAS) statistical data for gut microbiota and NAFLD/NASH were obtained from MiBioGen and FinnGen respectively...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38104027/relationship-between-educational-attainment-and-non-alcoholic-fatty-liver-disease-a-two-sample-mendelian-randomization-study
#34
JOURNAL ARTICLE
Zhewen Ren, Anke Wesselius, Coen D A Stehouwer, Martijn C G J Brouwers
BACKGROUND: Observational studies have identified an inverse association between education and non-alcoholic fatty liver disease (NAFLD). However, it is not possible to establish causality for this relationship. AIMS: To gain more insight into the causal nature of the relationship between education and NAFLD. METHODS: We performed two-sample Mendelian randomization (MR) analyses using summary-level, large-scale datasets to study the association of genetically predicted educational attainment (n = 1271 genetic instruments, obtained from 1,131,881 participants) with risk of NAFLD (i...
December 15, 2023: Digestive and Liver Disease
https://read.qxmd.com/read/38103266/iron-status-and-non-alcoholic-fatty-liver-disease-a-mendelian-randomization-study
#35
JOURNAL ARTICLE
Kexin Sun, Jie V Zhao, Edmund Anthony Severn Nelson, Vincent Wai Sun Wong, Hugh Simon Hung San Lam, Lai Ling Hui
OBJECTIVES: The aim of this study was to assess the association of genetically determined iron status with the risk for non-alcoholic fatty liver disease (NAFLD) using two-sample Mendelian randomization (MR) analysis. METHODS: We applied single nucleotide polymorphisms (SNPs) associated at genome-wide significance with iron status proxied by serum iron, ferritin, transferrin, and transferrin saturation from the Genetics of Iron status Consortium (N = 48 793), in a genome-wide association study of 1664 NAFLD cases and 400 055 controls from the United Kingdom Biobank...
November 2, 2023: Nutrition
https://read.qxmd.com/read/38102730/a-mendelian-randomization-study-between-chronic-periodontitis-and-non-alcoholic-fatty-liver-disease
#36
JOURNAL ARTICLE
Li Tan, Yunbo He, Tianyi Wang, Xianhua Gao, Wei Fan, Bing Fan
BACKGROUND AND OBJECTIVE: Observational studies have suggested a potential association between non-alcoholic fatty liver disease (NAFLD) and chronic periodontitis (CP). However, these studies are prone to confounding factors. The aim of this study was to assess the causal relationship between NAFLD and CP using a two-sample bidirectional Mendelian randomization (MR) analysis method. METHODS: Datasets of CP and NAFLD were retrieved from the European database, and instrumental variables (IVs) related to exposure were selected for the MR analysis...
December 15, 2023: Journal of Periodontal Research
https://read.qxmd.com/read/38102060/the-relationship-between-genetic-liver-fat-and-coronary-heart-disease-is-explained-by-apob-containing-lipoproteins
#37
JOURNAL ARTICLE
Elias Björnson, Martin Adiels, Göran Bergström, Anders Gummesson
BACKGROUND: The relationship between genetically-driven liver fat and coronary heart disease (CHD) remains unclear. ApoB-containing lipoproteins are known causal factors for CHD and may explain this relationship. METHODS AND RESULTS: We conducted a genome-wide association study (GWAS) in the UK Biobank to identify genetic variants associated with liver fat. We then investigated the effects that these genetic variants had on both apoB-containing lipoproteins and CHD...
November 29, 2023: Atherosclerosis
https://read.qxmd.com/read/38095388/association-of-thyroid-disease-and-risk-of-fatty-liver-disease-an-exposure-wide-mendelian-randomization-study
#38
JOURNAL ARTICLE
H-F Zhang, Q-X Zhang, Y-H Feng, S-J Li, B-Y Xie
OBJECTIVE: Previous studies have often observed a possible association between thyroid and fatty liver diseases. The pathogenesis of both diseases is complex, with many confounding factors and controversies. We used a two-sample Mendelian randomization (MR) analysis to test the causality between thyroid disease and the risk of developing fatty liver disease. MATERIALS AND METHODS: All data were obtained from the genome-wide association studies (GWAS) Catalog database...
December 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38081191/segmental-quantification-of-hepatic-lipid-content-based-on-volumetric-mri-data-in-patients-with-suspected-iron-overload
#39
JOURNAL ARTICLE
Arthur P Wunderlich, Holger Cario, Stephan Kannengießer, Veronika Grunau, Michael Götz, Felix Hüttner, Johanna Backhus, Meinrad Beer, Stefan Andreas Schmidt
PURPOSE:  To investigate the segmental distribution of hepatic fat fraction, determined with MRI (MR proton density fat fraction, short MR-PDFF) in patients suspected of having liver iron overload. METHODS:  The liver of 44 patients examined with MRI using a 3D multi-echo gradient-echo sequence was segmented semiautomatically and subdivided into nine segments (segment 4 divided in 4a and 4b). Segmental fat content was determined on MR-PDFF maps. Whole-liver steatosis grades were compared to those found in individual segments...
December 11, 2023: RöFo: Fortschritte Auf Dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
https://read.qxmd.com/read/38027213/causal-effects-of-nonalcoholic-fatty-liver-disease-on-cerebral-cortical-structure-a-mendelian-randomization-analysis
#40
JOURNAL ARTICLE
Zhiliang Mai, Hua Mao
BACKGROUND: Previous studies have highlighted changes in the cerebral cortical structure and cognitive function among nonalcoholic fatty liver disease (NAFLD) patients. However, the impact of NAFLD on cerebral cortical structure and specific affected brain regions remains unclear. Therefore, we aimed to explore the potential causal relationship between NAFLD and cerebral cortical structure. METHODS: We conducted a Mendelian randomization (MR) study using genetic predictors of alanine aminotransferase (ALT), NAFLD, and percent liver fat (PLF) and combined them with genome-wide association study (GWAS) summary statistics from the ENIGMA Consortium...
2023: Frontiers in Endocrinology
keyword
keyword
81351
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.